Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer

L. Magnani, G. Frigè, R.M. Gadaleta, G. Corleone, S. Fabris, H. Kempe, P.J. Verschure, I. Barozzi, V. Vircillo, S.-P. Hong, Y. Perone, M. Saini, A. Trumpp, G. Viale, A. Neri, S. Ali, M.A. Colleoni, G. Pruneri, S. Minucci

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)444-450
Number of pages7
JournalNature Genetics
Issue number3
Publication statusPublished - 2017

Cite this